WELLELL Business Summary

Wellell Inc. (4106.TW) is a prominent medical device manufacturer that generates revenue through the global distribution of specialized healthcare solutions, primarily organized into Pressure Injury Prevention (PIP), Respiratory Therapy, and Welfare Equipment segments. The PIP segment focuses on high-performance alternating pressure mattress systems and therapeutic support surfaces for wound management in acute and long-term care. Its Respiratory Therapy division provides Continuous Positive Airway Pressure (CPAP) systems for sleep apnea, while the Welfare Equipment segment includes medical beds and mobility aids. Wellell has increasingly shifted toward a value-added business model by integrating IoT-enabled digital health platforms that offer remote patient monitoring and data analytics. The company competes directly with global incumbents such as Baxter (Hill-Rom), Arjo, ResMed, and Philips Respironics, successfully positioning itself as a premium, technology-driven alternative with a strong foothold in the European and Asian medical markets. Founded in 1990, Wellell is led by its founder, Yong-Chuan Li, who serves as the current Chairman and Chief Executive Officer, steering the company’s strategic evolution from an OEM provider to a global brand. The leadership team was recently expanded with the appointment of Su Ya-Ling as Chief Operating Officer in March 2026, tasked with enhancing operational efficiency and global market penetration. The executive core is comprised of veterans in biomedical engineering and international healthcare management, ensuring robust R&D and regulatory compliance. As a publicly traded entity on the Taiwan Stock Exchange, Wellell is supported by a board of directors with deep expertise in industrial technology and is backed by institutional investors focused on the medical technology sector, providing the financial stability necessary for its continued expansion into digital health and smart care solutions.